Previous Article | Next Article ![]()
Journal of Virology, May 1999, p. 4427-4432, Vol. 73, No. 5
Harvard AIDS Institute, Department of
Immunology and Infectious Diseases, Harvard School of Public
Health, Boston, Massachusetts 02115,1 and
Theoretical Biology and Biophysics, Group T-10, Los Alamos
National Laboratory, Los Alamos, New Mexico
87545,2 and AIDS/STD
Unit3 and Princess Marina
Hospital,4 Gaborone, Botswana
Received 16 October 1998/Accepted 4 February 1999
To better understand the virological aspect of the expanding AIDS
epidemic in southern Africa, a set of 23 near-full-length clones of
human immunodeficiency virus type 1 (HIV-1) representing eight AIDS
patients from Botswana were sequenced and analyzed phylogenetically.
All study viruses from Botswana belonged to HIV-1 subtype C. The
interpatient diversity of the clones from Botswana was higher than
among full-length isolates of subtype B or among a set of full-length
HIV-1 genomes of subtype C from India (mean value of 9.1% versus 6.5 and 4.3%, respectively; P < 0.0001 for both
comparisons). Similar results were observed in all genes across the
entire viral genome. We suggest that the high level of HIV-1 diversity
might be a typical feature of the subtype C epidemic in
southern Africa. The reason or reasons for this diversity are unclear,
but may include an altered replication efficiency of HIV-1 subtype C
and/or the multiple introduction of different subtype C viruses.
The majority of new human
immunodeficiency virus (HIV) infections in the global AIDS epidemic are
appearing in sub-Saharan Africa and Southeast Asia. Compared with the
situation a decade ago, the main AIDS epidemics have shifted from
central and eastern Africa to the southern regions. The most severe HIV
epidemics have recently afflicted such southern African countries as
Zimbabwe, Zambia, Namibia, South Africa, and Botswana
(43). HIV-1 subtype C has been estimated to account for 48%
of HIV-1 infections worldwide and 51.5% of HIV-1 infections in Africa
(4, 7, 14-16, 21, 31), where the main mode of transmission
is heterosexual (43, 44, 47).
A rapid expansion of the HIV-1 epidemic in Botswana has
occurred since the early to mid 1990s. According to the UNAIDS and World Health Organization (WHO) Global HIV/AIDS & STD
Surveillance data, HIV prevalence among antenatal clinic attendees
tested in the major urban areas of Botswana (Gaborone, Francistown,
and Selebi-Phikwe) increased from 6% in 1990 to 39% in 1997 (range of
34 to 43%) (42). Among women 20 to 29 years of age, 43 to 44% tested HIV positive. Outside of the major urban areas, median HIV
prevalence increased from no evidence of infection in 1985 to 1987 to
34% in 1997. In 1997, HIV prevalence in Botswana ranged from 28 to
38%. As such, locally circulating HIV-1 needs to be characterized
thoroughly, and vital information about the nature of the epidemic
should be extended (2, 4, 7, 21, 31, 37, 45-47). Moreover,
Botswana's central geographic position makes a comprehensive HIV-1
molecular epidemiological study that much more urgent, because it may
serve as an example of the burgeoning epidemic in southern Africa.
In this study, we report the molecular cloning and phylogenetic
analysis of 23 near-full-length clones from Botswana. All of them
were identified as belonging to HIV-1 subtype C and demonstrated high
levels of intersample diversity across the entire viral genome. By
providing new genetic information regarding locally circulating viruses, this study may contribute to AIDS vaccine design for the
southern Africa region countries and, in particular, for Botswana.
Specimens for this study were selected from HIV-seropositive patients
in Gaborone, Botswana. All HIV-1 infections in this study were
likely to be heterosexually acquired. The times of infection were not
known. The HIV-1-seropositive status of patients was confirmed by
enzyme-linked immunosorbent assay and Western blot analysis. Clinical
classification was performed by using the 1987 Centers for Disease
Control and Prevention (CDC) revised classification (9)
(data not shown).
Genomic DNA was obtained directly from the patients' peripheral blood
mononuclear cells (PBMCs) A multiple alignment procedure for the full-length HIV
genome was performed by using the hidden Markov model.
Constructed through the HIV-1 HMMER computer program of the Los Alamos
National Laboratory, the model has been previously shown to provide the best description of the true nucleotide substitution pattern of HIV-1
gag and env genes (26). The HIV-1
HMMER model (11, 12) constructed at Los Alamos National
Laboratory for the full-length HIV-1 genomes (24) was
employed. Sixty full-length reference sequences were included in the
alignment from the GenBank data bank (5). The 3' end of the
alignment, which included the nef coding region and 3' long
terminal repeat (LTR), was adjusted manually. The pairwise
evolutionary distances from nucleotide sequences were computed by the
DNADIST program under Kimura's two-parameter model (17).
All alignments were globally gap stripped for the generation of the
trees. The transition/transversion ratio parameters were set at 3.0 for
the gag gene, 1.5 for the env gene, 1.42 for the
V1-V2 and V3 fragments, and 2.0 for the other viral loci
(25). A tree was drawn by the Njplot (33) and
TreeView (32) programs. To analyze patterns of
variability along the HIV-1 genomes, the program SWAN, which utilizes a
"sliding window" approach was used (34). Positions with
gaps either were or were not excluded from the analysis. The
variability distribution was estimated as an entropy function of
the nucleotide variation observed at a particular position. The
Recombinant Identification Program (RIP) (40) and HIV-1
Subtyping Basic BLAST (3) were used in searching for
recombination among the clones studied.
Sequence analysis of the Botswana HIV-1 revealed that 10 of 23 clones had an intact genomic organization with open reading frames. The
other clones had point mutations and/or insertions and deletions
resulting in frameshifts, disabled start codons, or premature stop
codons. No major deletions or rearrangements were observed. Determined
length polymorphism among studied sequences was limited to the
vpu (15- to 18-nucleotide [nt] insertion at the 5' end),
env (from 3- to 9-nt deletions to 48-nt insertions, GIGRGQ
motif in the BW17 V3 loop), 2nd exon of rev (a 13-amino-acid truncation at the 3' end), nef (6- to 15-nt deletions in
some clones), and regulatory regions of the LTR (three or four NF- An evolutionary tree in Fig. 1 shows the
phylogenetic relationship of the full-length Botswana clones to
other representative full-length HIV-1 sequences. All Botswana
sequences, a set from India (27), and two subtype C
reference sequences (C-ETH2220 [38] and C-92BR025
[19]) clustered together, forming a compelling subtype
C outcropping on the phylogenetic tree. This cluster was separated from
other HIV-1 sequences by the extremely high bootstrap value of 1,000 (out of 1,000 resampling). Phylogenetic relationships within the
subtype C bush were also noteworthy. Assuming that the circled node at
the center of the bush could represent the potential ancestral subtype
C node, we observed the following. (i) The star-like phylogeny of the
subtype C bush together with its branching order may demonstrate the
relatively high diversity of the Botswana samples. (ii) Four
Botswana sample clones (BW01, BW05, BW15, and BW16), together with
all five sequences from India, formed a potential subcluster, although
the bootstrap value was not high. (iii) All Indian samples were
separated by bootstrap values of 1,000, possibly reflecting a
"founder effect" among these sequences. (iv) Three Botswana
sample clones (BW04, BW11, and BW12) may represent individualized
groups of sequences inherited from a common subtype C ancestor.
(v) Two reference sequences ETH2220 and 92BR025 deviated together
with a high bootstrap value (1,000), possibly reflecting another
subtype C subcluster differing significantly from Botswana or
Indian samples. (vi) One of the Botswana samples (BW17)
strayed rather far off the main subtype C bush and may be the least
representative of Botswana HIV-1 samples. (vii) The topology of the
Botswana clones confirms that clones of the same samples are
closely related to each other based on full-length genome sequences. A
multilocus analysis was congruent with full-genome phylogenetic
analysis and confirmed clustering of newly derived Botswana clones
within subtype C across the entire HIV-1 genome (data not shown).
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Cloning and Phylogenetic Analysis of
Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
buffy coats
without passage through cell
culture or donor PBMCs. All clones in this study were amplified in
heminested PCR with three primers from the LA set (18) or
their modifications. The Expand Long Template PCR system (Boehringer
Mannheim, Indianapolis, Ind.) was used according to the manufacturer's
instructions. Gel purification of the first-round PCR product was
essential for direct amplification of 9.0-kb fragments from uncultured
PBMCs. Estimation of the expanded PCR sensitivity (based on 8E5/LAV)
revealed a successful amplification of the 9.0-kb fragment in the first
round when at least 8 × 102 to 4 × 103 proviral copies were present in the reaction (data not
shown). These results were consistent with those from other studies
(10, 39). The TA pCR2.1 TOPO system (Invitrogen, Carlsbad,
Calif.) and JM109 competent cells (Promega Corporation, Madison, Wis.) were used for cloning. Positive colonies were screened by PCR. To
obtain sufficient plasmids for sequence analysis, we amplified the constructs under the previously described conditions with some
modifications (41). Purified plasmid DNA served as a
template for sequencing. Both-strand sequencing was combined with a
strategy involving overlapping sequences. Dye terminator sequencing
on an automated DNA Sequenator (model 373A; Applied Biosystems, Inc., Foster City, Calif.) was used.
B sites with GGGACTTTCT as a potential fourth NF-
B in two
clones of BW05).

View larger version (28K):
[in a new window]
FIG. 1.
Phylogenetic relationship of the newly characterized
full-length clones from Botswana (boxed in black) to other
representative full-length HIV-1 sequences of subtypes A, B, C, D, F,
and H and recombinant subtypes AE, AG, and BF. Full-length subtype C
sequences from India were also included in the analysis. A
neighbor-joining tree was constructed on the basis of the hidden Markov
model nucleotide alignment of full-length HIV-1 genomes. Subtype O
ANT70 sequence was used as an outgroup. Values along the branches
indicate the bootstrap values that support branching (out of a 1,000 resampling).
To characterize the level of variability among Botswana clones across the entire HIV-1 genome, we performed SWAN program analysis as an entropy function of the nucleotide variation. The Botswana set had greater variability than subtype B samples (Fig. 2) (mean values of 11.6 and 8.5%, respectively, for gap-stripped analysis). The profiles of viral variability across the HIV-1 genome were similar among subtype B and C viruses. Comparison of gap-stripped and gap-nonstripped plots revealed that the differences in mean values between the two methods of computing and the shape of variability plot profiles were not significant (data not shown). Gap stripping slightly decreased the mean value and the number of sliding window sites across the genome. It also hid the extreme regions with the highest level of variability. Both variability when measured as an entropy function in this study and when described before diversity as a pairwise comparison of the sequence (19) exhibited similar profiles of variable and conservative genomic regions. Variability plots (especially non-gap stripped) revealed higher peaks in variable regions than diversity plots.
|
Table 1 depicts the high degree of
intersample diversity across the entire HIV-1 genome among Botswana
clones compared with subtype B and C sequences from India
(27). Because AIDS patients might be expected to have higher
variability, we made the same comparison, limiting the subtype B
reference to eight sequences selected from confirmed AIDS patients
(column 2). The intersample diversity among Botswana clones was
significantly higher than that among subtype B references or Indian
samples on the level of the full-length HIV-1 genome. Across the viral
genome, the mean diversity among Botswana samples was congruent
with the full-length genome analysis. The intersample diversity
analysis statistically confirmed the phylogenetic study observations
(Fig. 1 and 2) that the newly characterized Botswana clones were
highly diversified.
|
The results of intrasample diversity analysis were limited by the methods used (PCR amplification and cloning) and by the available number of multiple subtype B full-length clones. Seven Botswana samples (except BW12) and three subtype B sets (JRFL, YU, and ACH320) were compared across the HIV-1 genome. The range of full-length diversity among Botswana samples was 0.3% (BW17 clones) to 2.9% (BW04 clones), with an average mean value of 1.4%. Intrasample diversity showed no significant difference between subtype B and C sequences (Fig. 3). However, two concentrations of diversity (low and high) were revealed among both subtype B and C sets (Fig. 3). These concentrations of low and high diversity were distributed across the entire genome and were found to be more consistent in the structural genes (gag, pol, and env).
|
All Botswana sequences were checked for potential recombination sites by the HIV-1 Subtyping Basic BLAST (3) and by RIP (40), the results consistently showing no evidence of recombination.
Clustering with HIV-1 subtype C and the high intersample diversity were the most exceptional attributes of the 23-clone set from Botswana. A star-like shape of the subtype C cluster in the phylogenetic tree was accompanied by extremely high bootstrap values across tree branches. The topology of the phylogenetic tree suggested that a common ancestor for the Botswana sequences might have existed before the common ancestor for the Indian sequences analyzed or before the strains C-92BR025 (Brazil) and C-ETH2220 (Ethiopia) diverged.
Intersample diversity within subtype C has been previously found to vary from 5 to 11.5% (1, 7, 38). Higher levels of diversity were found among Botswana clones in this study, in spite of the fact that samples were taken from one place and at one time point. Both full-genome sequences and multiple subgenomic loci demonstrated the same patterns, with a higher mean value of variability among the Botswana samples.
The increased genetic diversity of subtype C viruses in Botswana
might have different underlying causes, including a variety of host and
viral factors. Among the latter factors, a combination of the genetic
flexibility of subtype C virus and its multiple introductions might be
the most important. A number of recent findings argue that one possible
cause of the high viral diversity in the Botswana epidemic could be
higher flexibility of subtype C virus and its altered ability to
diversify. These arguments include, but are not limited to the
following. (i) Subtype C is predominant in most recent HIV-1 epidemics
worldwide (1, 7, 27, 35, 36, 38, 45, 47). (ii) The highest
prevalence of HIV-1 infection in various epidemics is caused mainly
by subtype C virus. (iii) Subtype C virus may have a faster disease
progression (20), and patients infected with HIV-1
subtype C developed AIDS earlier than patients with subtype A
virus (23). (iv) Three or four NF-
B sites (instead
of two) might lead to more efficient viral transcription
(13, 29, 30). (v) The TNF-
response to subtype C virus is
significantly higher than to HIV-1 subtype B (28, 29),
suggesting the possibility of increased viral transcription and
replication in correlation with NF-
B copy number (28,
29). (vi) The viral load of subtype C infections may be higher in
different compartments that might cause an increased level of viral
transmission (22). On the other hand, a scenario that suggests independent diversification of the virus in other regions
and delayed entry of the epidemic in Botswana, followed by multiple
introductions of the subtype C virus from adjacent countries
cannot be excluded (42-44).
Botswana is geographically located at the center of the AIDS epidemic in Southern Africa. UNAIDS and World Health Organization surveillance data suggest that the widespread rise of the HIV-1 epidemic in Botswana started in the early to mid-1990s and reached one of the highest prevalence rates in Africa (42-44). For more recent HIV-1 epidemics, such as those described in Thailand and India, one might expect to find a highly homogeneous pool of local viruses that formed a monophyletic phylogenetic subcluster with relatively short and aggregated branches. However the findings in this study contradict the established trend.
Extremely high interpatient diversity across the genome was supported by long branch lengths in the phylogenetic trees throughout the Botswana viruses within the genetic subtype C. No multiple subtypes or recombination were found in this study. Because it currently has the highest incidence rates of HIV-1, the region of southern Africa, including Botswana and Zimbabwe, is an important site for the design and development of an anti-HIV vaccine. Recent studies of cross-clade cytotoxic T-lymphocyte recognition (6, 8, 48) have made a significant contribution to AIDS vaccine development. However, the extent of cross-clade immune responses in a highly diverse HIV-1 environment and the mechanism of vaccination throughout different HLA profiles in the population are still open questions. HIV-1 strains circulating locally (or appropriate combinations of local strains) should provide a more effective prototype or candidate for a vaccine than a distinct virus circulating elsewhere. As such, a comprehensive molecular epidemiology study of locally circulating HIV-1 strains would facilitate the design of an effective AIDS vaccine for a particular population, country, or geographic region.
Nucleotide sequence accession number. The 23 full-length HIV-1 sequences from Botswana are available under GenBank accession no. AF110959 to AF110981.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported in part by OIG grant R35 CA39805-13 from the National Institutes of Health and grant D43 TW00004 from the Fogarty International Center, National Institutes of Health.
We thank Bette T. Korber for critical analysis, Suranjana Choudhury for HIV-1 culturing, Peter Gilbert for help with statistical analysis, and Rajiv Rawat for editorial assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Immunology and Infectious Diseases, Harvard School of Public Health, FXB-402, 651 Huntington Ave., Boston, MA 02115. Phone: (617) 432-0975. Fax: (617) 739-8348. E-mail: messex{at}sph.harvard.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abebe, A., C. L. Kuiken, J. Goudsmit, M. Valk, T. Messele, T. Sahlu, H. Yeneneh, A. Fontanet, F. De Wolf, and T. F. Rinke De Wit. 1997. HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res. Hum. Retroviruses 13:1071-1075[Medline]. |
| 2. | Alaeus, A., T. Leitner, K. Lidman, and J. Albert. 1997. Most HIV-1 genetic subtypes have entered Sweden. AIDS 11:199-202[Medline]. |
| 3. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipmann.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 4. | Becker, M. L. B., G. de Jager, and W. B. Becker. 1995. Analysis of partial gag and env gene sequences of HIV type 1 strains from Southern Africa. AIDS Res. Hum. Retroviruses 11:1265-1267[Medline]. |
| 5. |
Benson, D. A.,
M. S. Boguski,
D. J. Lipman,
J. Ostell, and B. F. F. Ouellette.
1998.
GenBank.
Nucleic Acids Res.
26:1-7 |
| 6. | Betts, M. R., J. Krowka, C. Santamaria, K. Balsamo, F. Gao, G. Mulundu, C. Luo, N. N'Gandu, H. Sheppard, B. H. Hahn, S. Allen, and J. A. Frelinger. 1997. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J. Virol. 71:8908-8911[Abstract]. |
| 7. | Bredell, H., C. Williamson, P. Sonnenberg, D. J. Martin, and L. Morris. 1998. Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. AIDS Res. Hum. Retroviruses 14:677-684[Medline]. |
| 8. | Cao, H., P. Kanki, J.-L. Sankalé, A. Dieng-Sarr, G. P. Mazzara, S. A. Kalams, B. Korber, S. Mboup, and B. D. Walker. 1997. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol. 71:8615-8623[Abstract]. |
| 9. | Centers for Disease Control and Prevention. 1987. Centers for Disease Control and Prevention: revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid. Mortal. Weekly R.P. 36(Suppl 1):S1-S15. |
| 10. | Dittmar, M. T., G. Simmons, Y. Donaldson, P. Simmonds, P. R. Clapham, T. F. Schulz, and R. A. Weiss. 1997. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J. Virol. 71:5140-5147[Abstract]. |
| 11. | Eddy, S. R. 1996. Hidden Markov models. Curr. Opin. Struct. Biol. 6:361-365[Medline]. |
| 12. | Eddy, S. R. April 1995, posting date. HMMER. [Online.] http://hmmer.wustl.edu/. [15 October 1998, last date accessed.] |
| 13. |
Englund, G.,
M. D. Hoggan,
T. S. Theodore, and M. A. Martin.
1991.
A novel HIV-1 isolate containing alterations affecting the NF- B element.
Virology
181:150-157[Medline].
|
| 14. | Esparza, J. 1998. Personal communication. |
| 15. | Essex, M. 1998. State of the HIV pandemic. J. Hum. Virol. 1:427-429. [Medline] |
| 16. | Essex, M. Human immunodeficiency viruses of the developing world. Semin. Virol., in press. |
| 17. | Felsenstein, J. 1993. PHYLIP: phylogeny inference package, 3.52c ed. University of Washington, Seattle. |
| 18. | Fujii, S., K. Obaru, S. Matsushita, T. Morikita, H. Higuchi, K. Fujimoto, and K. Takatsuki. 1997. Characterization of proviral DNA from an individual with long-term, nonprogressive infection with HIV-1 and nonrecoverable virus. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:247-256[Medline]. |
| 19. |
Gao, F.,
D. L. Robertson,
C. D. Carruthers,
S. G. Morrison,
B. Jian,
Y. Chen,
F. Barré-Sinoussi,
M. Girard,
A. Srinivasan,
A. G. Abimiku,
G. M. Shaw,
P. M. Sharp, and B. H. Hahn.
1998.
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.
J. Virol.
72:5680-5698 |
| 20. | Hoelscher, M., D. Eimannsberger, R. Cheingsong-Popov, B. Jordan-Harder, D. Mwakagile, H. Nkwera, T. Nukulila, L. Gurtler, and F. von Sonnenburg. 1997. A shift in age specific subtype distribution gives evidence for different pathogenicity of subtypes A and C. In Program of the 5th Annual HIV Dynamics & Evolution Conference, Santa Fe, N.Mex.. |
| 21. | Janssens, W., A. Buve, and J. N. Nkengasong. 1997. The puzzle of HIV-1 subtypes in Africa. AIDS 11:705-712[Medline]. |
| 22. | John, G., J. Neilson, P. Lewis, J. Overbaugh, R. W. Nduati, D. A. Mbori-Ngacha, and J. Kreiss. 1988. HIV-1 subtype and shedding of cervicovaginal HIV-1 DNA during pregnancy, abstr. 13117. In Program of the 12th World AIDS Conference, Geneva, Switzerland.. |
| 23. | Kanki, P. J., D. J. Hamel, J.-L. Sankale, C.-C. Hsieh, I. Thior, F. Barin, S. A. Woodcock, A. Gueye-Ndiaye, E. Zhang, M. Montano, T. Siby, R. Marlink, I. NDoye, M. E. Essex, and S. MBoup. 1999. HIV-1 subtypes differ in disease progression. J. Infect. Dis. 179:68-73[Medline]. |
| 24. | Korber, B., B. Foley, T. Leitner, F. McCutchan, B. Hahn, J. W. Mellors, G. Myers, and C. Kuiken (ed.). 1997. Human retroviruses and AIDS, p. I-1-I-127. Theoretical Biology and Biophysics, Group T-10, Los Alamos, N.Mex. |
| 25. | Leitner, T., B. Korber, D. Robertson, F. Gao, and B. Hahn. 1997. Updated proposal of reference sequences of HIV-1 genetic subtypes, p. III-19-III-24. In B. Korber, B. Foley, T. Leitner, F. McCutchan, B. Hahn, J. W. Mellors, G. Myers, and C. Kuiken (ed.), Human retroviruses and AIDS. Theoretical Biology and Biophysics, Group T-10 Los Alamos, N.Mex. |
| 26. | Leitner, T., S. Kumar, and J. Albert. 1997. Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J. Virol. 71:4761-4770[Abstract]. |
| 27. |
Lole, K. S.,
R. C. Bollinger,
R. S. Paranjape,
D. Gadkari,
S. S. Kulkarni,
N. G. Novak,
R. Ingersoll,
H. W. Sheppard, and S. C. Ray.
1999.
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.
J. Virol.
73:152-160 |
| 28. |
Montano, M. A.,
C. P. Nixon, and M. Essex.
1998.
Dysregulation through the NF- B enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter.
J. Virol.
72:8446-8452 |
| 29. | Montano, M. A., C. P. Nixon, T. P. Ndung'u, A. V. A. Novitsky, H. Bussman, D. Dickman, S. M. Gaolekwe,
and M. Essex. Transcriptional gain-of-function in TNF- mediated
activation of HIV-1 subtype C. Submitted for publication.
|
| 30. | Montano, M. A., V. A. Novitsky, J. T. Blackard, N. L. Cho, D. A. Katzenstein, and M. Essex. 1997. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 71:8657-8665[Abstract]. |
| 31. | Orloff, G. M., M. Kalish, L. J. Chiphangwi, K. E. Potts, C.-Y. Ou, G. Schochetman, G. Dallabetta, A. I. Saah, and P. G. Miotti. 1993. V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. AIDS Res. Hum. Retroviruses 9:705-706[Medline]. |
| 32. |
Page, R. D. M.
1996.
TREEVIEW: an application to display phylogenetic trees on personal computers.
Comp. Appl. Biosci.
12:357-358 |
| 33. | Perriere, G., and M. Gouy. 1996. WWW-query: an on-line retrieval system for biological sequence banks. Biochimie 78:364-369[Medline]. |
| 34. |
Proutski, V., and E. Holmes.
1998.
SWAN: sliding window analysis of nucleotide sequence variability.
Bioinformatics
14:467-468 |
| 35. | Ray, S., K. S. Lole, R. S. Paranjape, S. Kulkarni, D. Gadkari, H. Sheppard, and R. C. Bollinger. 1998. Cloning of full-length HIV-1 genomes from recent infections in India: recombination and CTL epitope, abstr. 11194. In Program of the 12th World AIDS Conference, Geneva, Switzerland.. |
| 36. | Renjifo, B., B. Chaplin, D. Mwakagile, P. Shah, F. Vannberg, G. Msamanga, D. Hunter, W. Fawzi, and M. Essex. 1998. Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. AIDS Res. Hum. Retroviruses 14:635-638[Medline]. |
| 37. | Salminen, M. O., J. K. Carr, D. L. Robertson, P. Hegerich, D. Gotte, C. Koch, E. Sanders-Buell, F. Gao, P. M. Sharp, B. H. Hahn, D. S. Burke, and F. E. McCutchan. 1997. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J. Virol. 71:2647-2655[Abstract]. |
| 38. | Salminen, M. O., B. Johansson, A. Sonnerborg, S. Ayehunie, D. Gotte, P. Leinikki, D. S. Burke, and F. E. McCutchan. 1996. Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res. Hum. Retroviruses 12:1329-1339[Medline]. |
| 39. | Salminen, M. O., C. Koch, E. Sanders-Buell, P. K. Ehrenberg, N. L. Michael, J. K. Carr, D. S. Burke, and F. E. McCutchan. 1995. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 213:80-86[Medline]. |
| 40. | Siepel, A. C., A. L. Halpern, C. Macken, and B. T. Korber. 1995. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res. Hum. Retroviruses 11:1413-1416[Medline]. |
| 41. | Trinh, T., J. Jesse, F. R. Bloom, and V. Hirsch. 1994. STBL2TM: an Escherichia coli strain for the stable propagation of retroviral clones and direct repeat sequences. Focus 16:78-80. |
| 42. | UNAIDS, and WHO. 22 June 1998, posting date. Global HIV/AIDS & STD Surveillance. Epidemiological fact sheets by country. [Online.] http://www.us.unaids.org/highband/document/epidemio/june98/fact_sheets/index.html. [15 October 1998, last date accessed.] |
| 43. |
UNAIDS, and WHO.
1998.
Report on the Global HIV/AIDS Epidemic June 1998.
UNAIDS and WHO, Geneva, Switzerland.
|
| 44. | UNAIDS, and WHO. 29 June 1998, posting date. The status and trends of the HIV/AIDS epidemic in the world. [Online.] http://www.us.unaids.org/highband/document/epidemio/map.pdf,Geneva. [15 October 1998, last date accessed.] |
| 45. | van Harmelen, J., H. Bredell, L. Morris, E. van der Ryst, S. Lyons, D. York, and C. Williamson. 1998. Determination of prevalent HIV-1 subtypes in South Africa and the construction of a gp120 DNA vaccine, abstr. 33218. In Program of the 12th World AIDS Conference, Geneva, Switzerland.. |
| 46. | van Harmelen, J., R. Wood, M. Lambrick, E. P. Rybicki, A. L. Williamson, and C. Williamson. 1997. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 11:81-87[Medline]. |
| 47. | Williamson, C., S. Engelbrecht, M. Lambrick, E. van Rensburg, R. Wood, W. Bredell, and A.-L. Williamson. 1995. HIV-1 subtypes in different risk groups in South Africa. Lancet 346:782[Medline]. |
| 48. | Wilson, S. E., S. L. Pedersen, J. C. Kunich, V. L. Wilkins, D. L. Mann, G. P. Mazzara, J. Tartaglia, C. L. Celum, and H. W. Sheppard. 1998. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res. Hum. Retroviruses 14:925-937[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»